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Mutation S233L in the 1B Domain of Keratin 1 Causes
Epidermolytic Palmoplantar Keratoderma with
‘‘Tonotubular’’ Keratin
Ana Terron-Kwiatkowski1, Maurice A.M. van Steensel2, Michel van Geel2, E. Birgitte Lane3,
W.H. Irwin McLean1 and Peter M. Steijlen2
Epidermolytic palmoplantar keratoderma (EPPK) is an autosomal dominant genodermatosis characterized by
epidermolytic hyperkeratosis restricted to the palm and sole epidermis. The disorder is normally associated
with dominant-negative mutations in the keratin 9 (K9) gene; however, a small number of cases have been
reported where causative mutations were identified in the K1 gene. Here, we present two unrelated Dutch EPPK
families with striking ultrastructural findings: tubular keratin structures in the cytoplasm of suprabasal cells.
Similar structures were reported previously in a German EPPK family and were termed ‘‘tonotubular’’ keratin.
After excluding the involvement of the K9 gene by complete sequencing, we identified a novel mutation, S233L,
at the beginning of the 1B domain of K1 in both families. Protein expression studies in cultured cells indicated
pathogenicity of this mutation. This is the first report of a genetic defect in this domain of K1. The unusual gain-
of-function mutation points to a subtle role of the 1B domain in mediating filament–filament interactions with
regular periodicity.
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INTRODUCTION
The epidermis is the first line of defence protecting the human
body from its external environment and the keratinocytes that
make up this important barrier tissue express specialized
structural molecules in order to resist mechanical insult (Lane
and McLean, 2004; Omary et al., 2004). The intermediate
filament cytoskeleton extending throughout the cytoplasm of
keratinocytes is the main stress-bearing structure in epithelial
tissues and is composed of keratins (Fuchs and Cleveland,
1998). These rod-like fibrous proteins form heteropolymers
consisting of at least one type I and one type II keratin
(Quinlan et al., 1994; Coulombe and Omary, 2002). Keratins
share a conserved protein domain organization with other
intermediate filament proteins, consisting of a central
a-helical rod domain flanked by globular head and tail
domains. Two short amino-acid sequences at the start and
end of the rod domain, termed the helix boundary motifs, are
hotspots for pathogenic mutations associated with keratiniz-
ing disorders (Irvine and McLean, 1999). Keratins exhibit
tissue- and differentiation-specific expression patterns, for
example, K1 and K10 are expressed in suprabasal cells
throughout the epidermis (Lane, 1993), whereas keratin
9 (K9) is a suprabasal keratin found only in palmoplantar
skin (Langbein et al., 1993).
The palmoplantar keratodermas are a highly heteroge-
neous group of genodermatoses where the primary clinical
phenotype is hyperkeratosis of thick skin (Stevens et al.,
1996). Classification of these disorders on the basis of pheno-
typic and morphological criteria has been difficult; however,
a revised classification system based on the knowledge of
the underlying genetic defects is now beginning to emerge
(McLean, 2003). Epidermolytic palmoplantar keratoderma
(EPPK; OMIM number 144200) is an autosomal dominant
disorder characterized by cytolysis, blistering, and a diffuse
pattern of keratoderma affecting both palms and soles
(Vo¨rner, 1901). The keratoderma is strictly limited to the
thick skin and typically has a well-circumscribed erythema-
tous border. The gene for this disease was mapped to the type
I keratin gene cluster where the K9 gene (gene symbol KRT9)
was localized (Reis et al., 1992). Subsequently, K9 mutations
were identified in EPPK families (Reis et al., 1994) and K9
defects have been reported in many populations (McLean,
2003). Most of the reported EPPK mutations have been
missense or small in-frame insertion–deletion mutations in the
helix boundary motifs of the K9 polypeptide (Human Inter-
mediate Filament Mutation Database, http://www.interfil.org).
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More recently, a few mutations have been reported in the
K1 gene causing a phenotype that can be clinically and
histologically difficult to distinguish from EPPK (Hatsell et al.,
2001; Terron-Kwiatkowski et al., 2002, 2004; Whittock et al.,
2002). The K1 mutations reported in families with a
presentation predominantly consisting of palmoplantar kerato-
derma are larger deletions in the K1 rod domain (Hatsell
et al., 2001; Terron-Kwiatkowski et al., 2002) or affect
domains with a more subtle role in keratin filament assembly,
such as the ISIS motif within the V1 domain (Kimonis et al.,
1994), or affect the V2 domain (Whittock et al., 2002). More
recently, we have shown that certain missense mutations in
the helix termination motif of K1 can lead to a phenotype
easily confused with Vo¨rner-type EPPK (Terron-Kwiatkowski
et al., 2004).
Here, we studied two apparently unrelated families with
EPPK where the keratin cytoskeleton of palmoplantar
suprabasal cells had a remarkable tubular morphology and
where the underlying genetic defect was a missense mutation
in the 1B domain of K1.
RESULTS
Clinical description
Two apparently unrelated Dutch kindreds (designated
Families L and J) presented with a phenotype entirely typical
of EPPK of the Vo¨rner type (Vo¨rner, 1901). Specifically, there
was a diffuse pattern of keratoderma affecting both the
palmar and plantar surfaces, with a well-circumscribed
erythematous margin (Figure 1). A plantar biopsy of an
affected member of Family L revealed epidermolytic changes
consistent with a diagnosis of EPPK (Figure 2a) and essentially
identical histology was observed in biopsy material from the
proband in Family J (not shown). In each of the families,
several generations were affected in a clear autosomal pattern
of inheritance, with many examples of male-to-male trans-
mission seen in both kindreds (pedigrees not shown).
Electron microscopy reveals tonotubular keratin
Very unusual ultrastructural changes in keratin morphology
were observed in suprabasal keratinocytes of plantar biopsy
material derived from affected members of both Families
L and J (Figure 2b–d). Rather than forming bundles of
Figure 1. Clinical presentation of epidermolytic palmoplantar keratoderma
(EPPK) in the proband from Family J. Affected persons in both EPPK Families J
and L studied here exhibit diffuse palmoplantar keratoderma with a well-
demarcated erythematous margin, shown here on the palm. Significantly,
there was no spread of the keratoderma onto the wrists as observed in other
‘‘K1 keratoderma’’ kindreds and there was no occurrence of hyperkeratosis
affecting other body sites, notably the flexures. Together with the epidermo-
lytic histology (see Figure 2), these features are quite typical of the Vo¨rner
form of epidermolytic palmoplantar keratoderma, commonly caused by
mutations in keratin 9.
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Figure 2. Histological and ultrastructural features of ‘‘tonotubular’’ keratin aggregation. (a) A semithin section of plantar epidermis from the proband in Family
L, stained with Alcian blue, shows extensive cytolysis of suprabasal cells diagnostic of epidermolytic palmoplantar keratoderma. Some suprabasal cells appear to
have large, densely staining inclusions (arrows). Basal cells (B) are normal. The histology of biopsy material from affected persons in Family J was essentially
identical (not shown). Bar¼ 20 mm. (b) Low-power electron micrograph of a suprabasal keratinocyte from the proband in Family J showing extensive vacuolation
and destruction of the cytoplasm (*). There are some very electron-dense aggregates in the cytoplasm (arrows) and a larger number of ‘‘whorls’’ of aggregated
keratin (W). N¼ nucleus. Bar¼ 2 mm. (c) High-power electron micrograph from the proband in Family J, showing details of a cytoplasmic keratin ‘‘whorl’’, as
seen in (b), above. At high power, the keratin is seen to form tubules that can be observed in transverse section (arrows) or in longitudinal section (arrowheads).
Bar¼100 nm. (d) High-power electron micrograph from the proband in Family L, again showing details of cytoplasmic keratin ‘‘whorls’’. Keratin tubules can be
seen in transverse section (arrows) or in longitudinal section (arrowheads). The bizarre morphology of the keratin in this unrelated patient is strikingly similar to
that seen in Family J, (c) above. Bar¼100 nm.
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tonofilaments, the suprabasal keratin instead formed tubular
structures, seen in both longitudinal and transverse sections
(Figure 2c and d). In some places, there was aggregation of
these structures, but within these conglomerates, the tubular
morphology could still be seen. There were electron-dense
aggregates more typical of EPPK in some places; however,
the ‘‘whorls’’ of keratin exhibiting the tubular phenotype
predominated (Figure 2b). Examination of the literature
revealed that virtually identical keratin morphology had been
described previously in a German kindred who also pre-
sented with EPPK (Wevers et al., 1991). These authors had
coined the term ‘‘tonotubular’’ keratin for these structures.
A novel 1B domain mutation in K1
As EPPK of the Vo¨rner type is known to be caused by
mutations in K9 (Reis et al., 1994), we initially screened this
gene in its entirety using DNA from the proband in Family L.
Although we detected a few previously reported polymorph-
isms (data not shown), we did not identify any potentially
pathogenic sequence changes in the coding sequences or
intronic splice sites of this gene.
As a subset of mutations in K1 have been associated with
different forms of palmoplantar keratoderma (Kimonis et al.,
1994; Whittock et al., 2002; Hatsell et al., 2001; Sprecher
et al., 2001; Terron-Kwiatkowski et al., 2002, 2004), we
screened the entire K1 gene in Family L and identified a
heterozygous transition mutation 698C4T in exon 2 (Figure
3a and b). This sequence change was present in the affected
individuals, but was absent from unaffected family members
and leads to a leucine to serine substitution at position 233 of
the K1 polypeptide, designated S233L. This mutation lies at
the beginning of the predicted helix 1B domain of the central
a-helical coiled-coil rod domain (Smith et al., 2002). Only
one other homozygous change 1072A4T was found in exon
5 of the proband of Family L, his unaffected son and one
unaffected control (data not shown). As it did not co-
segregate with the disease phenotype in the family and was
detected in unaffected controls, this could be excluded as a
pathogenic mutation, even though it predicts the amino-acid
change N358Y in the 2A domain of the K1 protein. The same
S233L mutation in K1 was also identified in all affected
members of Family J by direct sequencing (data not shown).
The presence of the K1 mutation S233L was confirmed by
denaturing high-performance liquid chromatography in all
affected members of Families L and J. In this assay, the
mutation produced clearly identifiable peaks corresponding
to heteroduplexes formed between the wild-type and mutant
alleles (Figure 3c). Subsequently, denaturing high-perfor-
mance liquid chromatography was used to rapidly exclude
the mutation from 94 Dutch and 74 British unaffected
controls. Affected and unaffected samples of Family L were
used as positive and negative controls, respectively. From the
populations screened, a total of 13 control samples presented
elution profiles different from that of a sequence-verified
unaffected control and were therefore sequenced. All
samples sequenced, including all samples from the two EPPK
families, had a silent polymorphism 720A4G (R240R in
the 1B domain) that differed from the published sequence
(GenBank Accession number AF237621). In addition, a
heterozygous 1762G4A polymorphism (G488R in the
variable V2 domain) was found to be common in both
Dutch and British populations (5/13 samples sequenced).
Remarkably, an additional heterozygous 800G4A change,
predicting the non-conservative amino-acid substitution
R267Y in the helix 1B domain, was found in one British
control who had no history of skin disease. This must
therefore be a rare non-pathogenic substitution polymorph-
ism in K1.
Functional analysis reveals a subtle filament aggregation
phenotype
As the mutation occurred in a part of the K1 protein not
previously associated with pathogenic mutations, we per-
formed transient transfection experiments using normal and
mutant keratin constructs in a keratinocyte cell line in order
to confirm that the S233L mutation in the 1B domain of K1 is
pathogenic and perhaps recapitulate the tubular keratin
morphology in a cell culture system. We used the human
keratinocyte cell line HaCaT (Boukamp et al., 1988), which
expresses the basal cell keratins K5 and K14 (Ryle et al.,
1989), reported to be a pre-requisite for the assembly of
keratins K1 and K10 (Kartasova et al., 1993; Paramio and
Jocarno, 1994). K1 and K10 are localized in the suprabasal
layer of the skin, and expression of these differentiation-
specific keratins in HaCaT cells appears to be dependent on
cell density (Ryle et al., 1989). Here, we found that using
Normal K1 exon 2 DHPLC analysis
Family J, I:2 (unaffected)
Family J, II:1 (affected)
Family J, II:2 (unaffected)
Family J, III:3 (affected)
Family L (unaffected)
Family L (affected)
K1 mutation S233L
C/T
C/C
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Figure 3. Molecular genetic analysis reveals a new mutation in the K1 helix
1B domain. (a) Normal K1 exon 2 sequence, showing forward strand
sequence covering codons 231–235, inclusive. (b) The same region of K1
exon 2 as shown in (a), above, derived from the proband in Family J. A
heterozygous 698C4T transition (arrow) was detected, predicting the S233L
missense mutation in the 1B domain of the K1 polypeptide. The same
mutation was found to co-segregate with the EPPK phenotype in both families.
(c) Confirmation of the S233L mutation in exon 2 of the K1 gene by
denaturing high-performance liquid chromatography in affected members of
Families J and L. Double peaks corresponding to the heteroduplexes formed
between the wild-type and mutant alleles are observed in samples carrying
the mutation.
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normal keratinocyte growth medium with a standard
concentration of calcium (which affects differentiation), there
was reasonable expression of K1 and K10 (data not shown).
The transfected K1 could pair another type I keratin, such as
the more widely expressed K14, and sub-optimal keratin
pairing might mask the effect of the mutation in filament
formation. To exclude this possibility, we reproduced the
equivalent of the K1 mutation S233L in type II keratin K5
(Q221L), the latter protein being constitutively expressed in
HaCaT cells (Ryle et al., 1989). To enable visualization of the
transfected keratins, all keratin constructs were tagged at the
N-terminus with enhanced green fluorescent protein (EGFP).
HaCaT cells were transiently transfected with wild-type
and mutant versions of the K1 and K5 constructs. At 72 hours
after transfection, morphologically normal keratin filaments
were present in most of the cells transfected with either wild-
type or the 1B mutant keratins (Figure 4a). In some cells, and
for all constructs regardless of mutation status, thicker
filaments could be observed in a perinuclear distribution
(not shown). These may correspond to the newly assembled
keratin filaments as described previously (Albers and Fuchs,
1987). In addition, with all constructs, some cells presented
small, irregular, densely staining punctate aggregates (Figure
4b). Electron microscopy was performed on transfected cells
to see if the mutant keratins recapitulated the tubular
morphology in this cell culture model; however, no tubular
structures were observed (data not shown). Nevertheless, a
lower proportion of cells with aggregates were observed
among those transfected with K1 wild-type (2.970.7%)
compared to the K1-S233L mutant constructs (3.971.3%).
Similar results were obtained for the equivalent K5
constructs. Specifically, K5 wild-type produced 11.372.2%
aggregates, versus K5 Q221L, which gave 15.372.1%
aggregates. Although these differences were not statistically
significant (P-value 40.10 combining data for K1 and K5; K1
w2¼0.243; or K5 w2¼ 1.410), these functional data, together
with exclusion of S233L from 336 normal chromosomes, is
indicative that this is a pathogenic mutation in K1.
DISCUSSION
Here, we have studied two large unrelated families who
presented with all the usual clinical hallmarks of Vo¨rner-type
EPPK: keratoderma in a diffuse pattern on palms and soles
with a well-defined erythematous margin; histology showing
epidermolytic changes; lack of involvement of non-glabrous
skin; and canonical signs of autosomal dominant inheritance
(Figures 1 and 2). Following exclusion of a mutation in the K9
gene by full genomic sequence analysis and genetic linkage
analysis, we identified a novel missense mutation S233L in
the 1B domain of the K1 polypeptide, which co-segregated
with disease phenotype in both families and was excluded
from 168 normal controls (Figure 3). Protein expression
analysis in cultured cells provided further evidence for
pathogenicity of this unique mutation. The Vo¨rner form EPPK
is predominantly caused by missense or small in-frame
insertion–deletion mutations in the helix boundary motifs of
K9 (Reis et al., 1994; Coleman et al., 1999). There are
currently 48 independently occurring mutations in K9 logged
in the Human Intermediate Filament Mutation Database
(http://www.interfil.org). Recently, a small number of families
have come to light exhibiting phenotypes that are very similar
to or are clinically indistinguishable from EPPK, but who
carry a mutation in K1 instead of the K9 gene (Hatsell et al.,
2001; Terron-Kwiatkowski et al., 2002, 2004). Some of these
families have, upon close examination, small areas of
epidermolytic hyperkeratosis on sites other than palm and
sole, typically this is seen as hyperkeratosis spreading onto
the wrist, or in a few cases, the flexures and other sites
(Terron-Kwiatkowski et al., 2004). Families J and L studied
here did not have any hyperkeratosis outside of the palm and
sole, and so were classified as Vo¨rner-type EPPK. Expression
of K1 and its type I keratin polymerization partner K10 is not
limited to thick skin, but instead, these keratins are expressed
in all regions of the epidermis (Lane, 1993). Dominant-
negative mutations in either of these keratins have largely
been associated with a more severe and widespread
phenotype, bullous congenital ichthyosiform erythroderma,
also known as epidermolytic hyperkeratosis (Cheng et al.,
1992; Chipev et al., 1992; Rothnagel et al., 1992). It was
recognized soon after the discovery that K1 and K10 are the
causative genes for bullous congenital ichthyosiform erythro-
derma/epidermolytic hyperkeratosis, and that this disorder
could be sub-divided into mainly palm/sole-affected (PS) and
non-palm/sole-affected (NPS) forms (DiGiovanna and Bale,
1994). Furthermore, the PS subtype could be further divided
into PS-1 (predominantly palm/sole) or PS-2 (palm/sole with
more widespread involvement and neonatal blistering). The
PS-1 and PS-2 presentations were caused by mutations in K1,
whereas the NPS presentation was caused by K10 mutations
(DiGiovanna and Bale, 1994). Using this very informative
DiGiovanni–Bale classification, the families studied here fit
clearly into the PS-1 category, and this is consistent with a K1
defect. It is difficult to explain why some mutations in K1 lead
to hyperkeratosis restricted to palm and sole epidermis. One
obvious explanation is that these sites undergo substantially
a b
Figure 4. The 1B domain mutation is detrimental to filament formation in
cultured cells. (a) HaCaT cells were transfected with K1 or K5 wild-type and
1B mutant GFP constructs. At 72 hours after transfection, keratin filaments of
essentially normal morphology were observed in cells transfected with all
constructs, as shown here with wild-type K1. (b) At shorter times following
transfection, cells with prominent, punctuate aggregates were also present in
all transfection experiments, exemplified here by K1 mutant S233L, at
48 hours post-transfection. Higher percentages of aggregates were observed
with both K1 and K5 mutants compared to their wild-type controls, indicative
of the pathogenicity of this mutation in the 1B domain.
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more physical trauma during everyday life. However, given
that the pattern of keratoderma in the patients studied here is
diffuse with well-demarcated boundaries rather than focal in
nature (Figure 1) is suggestive of a phenomenon related to
regionalized gene expression in the palm and sole, for
example, certain mutations may somehow perturb the
interaction of K1 with K9 more than its interaction with K10.
The most striking feature of Families J and L was the
bizarre tubular morphology of the tonofilaments observed
by electron microscopy (Figure 2b–d). This was essentially
identical in appearance to a previous report describing
‘‘tonotubular’’ keratin in a patient, which like those studied
here was diagnosed as having EPPK (Wevers et al., 1991).
The previously reported family originated in Germany and
therefore it is possible that they may represent distant
relatives of our two Dutch kindreds. We were unable to
obtain DNA for analysis from the German kindred, but in
view of the ultrastructural similarities, it seems very likely that
they will harbor the S233L mutation or a very similar defect
in K1. It is remarkable that a single amino-acid substitution in
the 1B domain of the K1 rod domain is responsible for
generating the tonotubular phenotype. Keratin rod domains
adopt a coiled-coil secondary structure owing to a heptad
repeat sequences (Crewther et al., 1983; Smith et al., 2002).
Within a heptad, the a and d positions are usually occupied
by hydrophobic residues that mediate leucine zipper inter-
actions in the formation of a keratin type I–type II dimer. The
serine mutated here in K1 (S233) occupies the f position
within the heptad repeat thus: ...ESF INNLRRR VDQLKSD...,
where S233 is in bold, and hydrophobic a and d residues
underlined. In the coiled-coil structure, amino acids in the f
position are on the outer face of the dimer. Thus, the mutant
leucine residue is in a position where it could cause an
aberrant hydrophobic interaction between adjacent keratin
dimers. We therefore postulate that this gain-of-function
mutation leads to tubular aggregation because of an
abnormal hydrophobic dimer–dimer and/or filament–filament
interaction. The overall result of the tubular aggregation and,
to a lesser extent, dense aggregation of keratins (Figure 2b)
are mechanical fragility of the suprabasal cells (Figure 2a),
leading to cytolysis, and ultimately epidermolytic hyperker-
atosis of palms and soles in the patients (Figure 1). It was
disappointing that expression of the K1 mutant and the
equivalent K5 mutation in HaCaT cells did not appear to
recapitulate the tubular morphology upon electron micro-
scopic analysis (data not shown). We postulate that this is
because of the obvious differences in morphology and gene
expression between a monolayer culture of a transformed cell
line compared to the living multilayered epidermis in vivo.
Perhaps, in stratifying cultures of stably transfected keratino-
cytes, the tubular keratin phenotype could be modelled,
allowing further study of this unusual structural phenomenon.
In summary, molecular genetic analysis has identified a
unique K1 mutation as the underlying cause of EPPK in a
subset of patients with ‘‘tonotubular’’ keratin (Wevers et al.,
1991). This sheds further light on the spectrum of phenotypes
that can arise from K1 mutations and helps in future
molecular classification of the keratodermas, which owing
to their extensive heterogeneity are a difficult group of geno-
dermatoses to define and diagnose on the basis of clinical
features alone.
MATERIALS AND METHODS
Clinical material
Patient materials were collected with informed consent using
protocols approved by an Institutional Review Board that complies
with all principles of the Declaration of Helsinki Principles Accord.
A punch biopsy was taken from palmoplantar skin of the probands in
Families L and J. Part of the biopsy was processed for standard
hematoxylin and eosin staining. The other part was processed for
electron microscopy as described previously. Genomic DNA was
obtained with informed consent from peripheral blood lymphocytes
using the Nucleon DNA Extraction Kit (Amersham Pharmacia
Biotech, Bucks, UK).
K9 mutation detection
Amplification of the entire 4.8 kb K9 gene (gene symbol KRT9) was
performed using 200 ng of each genomic DNA, with 1 mM each of
primers K9.C1 and K9.C2 (Table 1), 0.25 mM of each dNTP in
1 high-fidelity polymerase buffer with 1.5 mM MgCl2 and 4%
DMSO. High-fidelity Taq polymerase (1 U) (Roche Diagnostics,
Mannheim, Germany) was added to each sample after DNA
denaturation at 941C for 6 minutes. Long-range PCR was carried
out initially for 10 cycles of 941C, 30 seconds; 551C, 30 seconds; and
681C, 4 minutes. This was followed by another 25 cycles with
increasing extension times of 20 seconds/cycle and a final 10 min-
utes extension at 681C. PCR products were purified using QIA quick
PCR purification method (Qiagen, Crawley, UK) before DNA
sequencing on a ABI DNA sequencer (Applied Biosystems, Foster
City, CA) with internal primers: K9.p6, K9e7.L, and K9.C2 (Table 1).
K1 mutation detection
Exons 1 and 7 of the K1 gene (KRT1) were amplified using 200 ng of
each genomic DNA, 1 mM each of primer pairs K1e1.F&R or
K1e7.F&2R (Table 1), 0.25 mM of each dNTP, and 1 U Taq
polymerase (Promega, Southampton, UK) in 1 polymerase buffer
with 1.5 mM MgCl2 and 4% DMSO. Following DNA denaturation at
941C for 5 minutes, PCR was carried out for 35 cycles of 941C,
30 seconds; 551C, 45 seconds; and 721C, 90 seconds; with a final
5 minutes extension. Amplification of exons 2–6 and 8–9 was
performed similarly with primers described elsewhere (Whittock
et al., 2000) at an annealing temperature of 561C for 30 cycles. PCR
products were purified and sequenced as indicated above with each
forward and/or reverse primers.
K1 mutation confirmation and population screening
For analysis by denaturing high-performance liquid chromatogra-
phy, exon 2 of the K1 gene was performed using HotStar Taq system
(Qiagen), but otherwise the conditions were as stated above. PCR
products were subjected to denaturation at 951C for 5 minutes, and
thereafter renatured in 70 cycles of 22 seconds starting at 951C and
cooling 11C/cycle to allow heteroduplex formation. Denaturing
high-performance liquid chromatography was carried out using the
Wave System (Transgenomics, Crewe, UK) with 5–10 ml of each PCR
product at a melting temperature of 591C, as predicted for the 410 bp
exon 2 fragment by the WaveMaker program (Transgenomics). Any
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sample that showed a different elution profile compared to a normal
control was directly sequenced.
EGFP constructs
A wild-type human K1 construct tagged at the N-terminus with
EGFP, consisting of the entire K1 open-reading frame between EcoRI
and PstI sites in the pEGFP-C3 vector (Clontech, Palo Alto, CA), was
kindly donated by Dr Sarah Hatsell and Professor David Kelsell
(Centre for Cutaneous Research, St Bartholomew’s and The Royal
London School of Medicine and Dentistry, Queen Mary and
Westfield College, London, UK). A similar EGFP-K1 construct
carrying the S233L mutation construct was made by site-directed
mutagenesis using the QuickChange Kit (Stratagene, La Jolla, CA)
using K1-S233L/m-F and -R primers (Table 1), following the
manufacturer’s instructions.
A human K5 wild-type EGFP construct, consisting of the full-
length K5 cDNA between HindIII and EcoRI sites in the pEGFP-C2
vector (Clontech), was a gift from Dr Dan Gibbs (CRUK Laboratories,
School of Life Sciences, University of Dundee, Dundee, UK). A
similar EGFP-K5 construct carrying the missense mutation Q221L
(equivalent to the S233L mutation in K1) was made by site-directed
mutagenesis using K5-Q221L/m-F and -R primers (described in
Table 1). Wild-type and mutant plasmids were isolated using a
Plasmid Maxi kit (Qiagen) and further purified for transfection by the
standard phenol:chloroform method.
Keratinocyte transfection
HaCaT human keratinocyte cell line (Boukamp et al., 1988) was
grown at 371C and 5% CO2 in keratinocyte serum-free medium
(GIBCO-Invitrogen, Paisley, UK) supplemented with epidermal
growth factor (at 5 ng/ml), bovine pituitary extract (at 25 mg/ml),
penicillin (100 U/ml), and streptomycin (100 mg/ml). Transient trans-
fections were performed at 50% confluency with the lipofectin–
integrin–DNA method described previously (Hart et al., 1998). The
integrin receptor-specific peptide 6 described previously (Hart et al.,
1998) was obtained from Zinsser Analytic (Berks, UK) and the
Lipofectin from GIBCO-Invitrogen. Lipofectin–integrin–DNA complex
ratios (ml lipofectin:mg integrin:mg DNA) of 4:12:2, 3:8:2, 2:8:2,
and 2.25:12:3 were used to transfect the K1 wild-type and S233L
mutant EGFP constructs in four independent experiments. For
transfection, HaCaT cells were grown on 13 mm diameter glass
coverslips in 35 mm culture plates. Other transfection experiments
with K5 wild-type and Q221L mutant EGFP constructs were
performed in four-chamber slides at lipofectin–integrin–DNA com-
plex ratios of 1:2:0.5, 2:2:0.5, and 2:4:1. All lipofectin–integrin–DNA
mixtures were allowed to form complexes for 2 hours at room
temperature before transfection and the cells were washed 5 hours
after transfection. Thereafter, cells were grown in fresh keratinocyte
serum-free medium up to 72 hours post-transfection. For staining,
cells were fixed with 3% paraformaldehyde for 10 minutes, and
permeabilized with 0.2% Triton X-100 for 5 minutes. Nuclei were
stained with 1 mg/ml DAPI (4,6-diamidino-2-phenylindole; Sigma
Chemicals, Poole, UK) in phosphate-buffered saline. Hydromount
containing 2.5% DABCO (diazabicyclo[2,2,2]octane; Sigma) was
used to mount coverslips and slides. Cells were visualized using an
Olympus BX60 epifluorescent microscope and images captured
using the SmartCapture 2.1 (Digital Scientific, Cambridge, UK).
Statistical analysis of transfection experiments
Statistical analysis was carried out using the Microsoft Excel
program. The proportion of cells with keratin aggregates among
the transfected cell population for each K1 and K5 construct was
expressed as the percentage7the standard error. Comparison of
cells transfected with either wild-type or 1B mutant versions of K1 or
K5 was performed using the w2 test to calculate the P-value.
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